Marinus Pharmaceuticals
MRNS
$1.51
Share price
4.14%
Change (1 day)
-83.22%
Change (1 year)
Categories
Marinus Pharmaceuticals (MRNS) - Cash on Hand
Cash on Hand as of December 2023 : $0.15 B
According to Marinus Pharmaceuticals's latest financial reports the company has $0.15 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Marinus Pharmaceuticals - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.15 B | -37.52% |
| 2022-12-31 | $0.24 B | 95.69% |
| 2021-12-31 | $0.12 B | -12.18% |
| 2020-12-31 | $0.13 B | 52.68% |
| 2019-12-31 | $91.68 M | 26.07% |
| 2018-12-31 | $72.72 M | 36.21% |
| 2017-12-31 | $53.39 M | 77.38% |
| 2016-12-31 | $30.1 M | -46.44% |
| 2015-12-31 | $56.19 M | 13.02% |
| 2014-12-31 | $49.72 M | 395.37% |
| 2013-12-31 | $10.03 M | 16.25% |
| 2012-12-31 | $8.63 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $0.25 B | 69.59% | 🇺🇸 USA |
 Endo International
ENDPQ | $0.77 B | 417.62% | 🇮🇪 Ireland |
 AcelRx Pharmaceuticals
ACRX | $9.38 M | -93.76% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | $15.35 M | -89.78% | 🇺🇸 USA |